Bruker (BRKR) Competitors $42.19 +0.65 (+1.56%) Closing price 07/17/2025 04:00 PM EasternExtended Trading$42.59 +0.40 (+0.95%) As of 07/17/2025 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BRKR vs. TECH, A, IQV, MTD, RVTY, TMO, WAT, ILMN, CRL, and BIOShould you be buying Bruker stock or one of its competitors? The main competitors of Bruker include Bio-Techne (TECH), Agilent Technologies (A), IQVIA (IQV), Mettler-Toledo International (MTD), Revvity (RVTY), Thermo Fisher Scientific (TMO), Waters (WAT), Illumina (ILMN), Charles River Laboratories International (CRL), and Bio-Rad Laboratories (BIO). Bruker vs. Its Competitors Bio-Techne Agilent Technologies IQVIA Mettler-Toledo International Revvity Thermo Fisher Scientific Waters Illumina Charles River Laboratories International Bio-Rad Laboratories Bruker (NASDAQ:BRKR) and Bio-Techne (NASDAQ:TECH) are both mid-cap life sciences tools & services companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership. Do insiders & institutionals believe in BRKR or TECH? 79.5% of Bruker shares are held by institutional investors. Comparatively, 99.0% of Bio-Techne shares are held by institutional investors. 27.3% of Bruker shares are held by company insiders. Comparatively, 3.9% of Bio-Techne shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to BRKR or TECH? In the previous week, Bio-Techne had 17 more articles in the media than Bruker. MarketBeat recorded 25 mentions for Bio-Techne and 8 mentions for Bruker. Bruker's average media sentiment score of 1.06 beat Bio-Techne's score of 0.68 indicating that Bruker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bio-Techne 13 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, BRKR or TECH? Bio-Techne has lower revenue, but higher earnings than Bruker. Bio-Techne is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBruker$3.37B1.90$113.10M$0.5281.13Bio-Techne$1.16B7.21$168.10M$0.8264.99 Is BRKR or TECH more profitable? Bio-Techne has a net margin of 10.89% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 19.47% beat Bio-Techne's return on equity.Company Net Margins Return on Equity Return on Assets Bruker2.31% 19.47% 5.95% Bio-Techne 10.89%13.17%10.17% Is BRKR or TECH a better dividend stock? Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.5%. Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.6%. Bruker pays out 38.5% of its earnings in the form of a dividend. Bio-Techne pays out 39.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Which has more risk and volatility, BRKR or TECH? Bruker has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, Bio-Techne has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Do analysts prefer BRKR or TECH? Bruker presently has a consensus price target of $52.89, indicating a potential upside of 25.36%. Bio-Techne has a consensus price target of $70.00, indicating a potential upside of 31.36%. Given Bio-Techne's stronger consensus rating and higher possible upside, analysts clearly believe Bio-Techne is more favorable than Bruker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bruker 0 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.40Bio-Techne 0 Sell rating(s) 6 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryBio-Techne beats Bruker on 12 of the 18 factors compared between the two stocks. Get Bruker News Delivered to You Automatically Sign up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BRKR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BRKR vs. The Competition Export to ExcelMetricBrukerINSTRU IndustryComputer SectorNASDAQ ExchangeMarket Cap$6.29B$1.09B$28.47B$9.34BDividend Yield0.48%0.48%3.10%4.06%P/E Ratio81.1331.9833.5019.86Price / Sales1.901.391,777.4699.92Price / Cash11.5727.5437.8657.94Price / Book3.563.217.665.67Net Income$113.10M$17.67M$779.03M$257.80M7 Day Performance-3.65%-5.76%2.02%1.86%1 Month Performance9.78%12.14%7.14%10.91%1 Year Performance-32.52%-20.41%52,800.98%18.51% Bruker Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BRKRBruker4.9783 of 5 stars$42.19+1.6%$52.89+25.4%-34.2%$6.29B$3.37B81.1311,396Positive NewsTECHBio-Techne4.875 of 5 stars$51.53-3.0%$72.00+39.7%-31.9%$8.08B$1.16B62.843,100AAgilent Technologies4.732 of 5 stars$119.21-1.8%$140.92+18.2%-12.8%$33.86B$6.51B29.4317,900IQVIQVIA4.9034 of 5 stars$162.57-1.0%$226.32+39.2%-29.0%$28.12B$15.41B22.1588,000Upcoming EarningsMTDMettler-Toledo International4.1511 of 5 stars$1,188.28-1.7%$1,300.36+9.4%-12.5%$24.69B$3.87B29.6317,300Positive NewsRVTYRevvity3.5785 of 5 stars$98.68-2.6%$123.64+25.3%-15.7%$11.63B$2.76B41.9911,000TMOThermo Fisher Scientific4.9925 of 5 stars$418.76-2.5%$604.05+44.2%-23.4%$158.08B$42.88B24.56125,000Positive NewsUpcoming EarningsWATWaters4.8144 of 5 stars$346.35-1.1%$388.00+12.0%-5.4%$20.61B$2.96B31.437,600Trending NewsAnalyst DowngradeILMNIllumina4.8547 of 5 stars$97.15-3.6%$127.39+31.1%-18.3%$15.38B$4.37B-16.009,030CRLCharles River Laboratories International4.723 of 5 stars$153.93-2.0%$171.85+11.6%-29.7%$7.56B$4.05B-236.8220,100BIOBio-Rad Laboratories4.6436 of 5 stars$247.45-1.6%$324.25+31.0%-21.6%$6.73B$2.57B-3.257,700 Related Companies and Tools Related Companies TECH Competitors A Competitors IQV Competitors MTD Competitors RVTY Competitors TMO Competitors WAT Competitors ILMN Competitors CRL Competitors BIO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BRKR) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhat’s the “Golden Anomaly”… and how can you profit?Trump’s “Big Beautiful Bill” passed! That means the US is on track for $60 trillion in debt by 2035 – by the g...Golden Portfolio | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bruker Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Bruker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.